![Jill DeSimone](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jill DeSimone
Direktor/Vorstandsmitglied bei
PRAXIS PRECISION MEDICINES, INC.
Vermögen: 719 399 $ am 31.07.2026
Profil
Jill Mary DeSimone is currently an Independent Non-Executive Director at Indegene Ltd. since 2026, an Independent Director at Praxis Precision Medicines, Inc. since 2022, an Independent Director at Oncternal Therapeutics, Inc. since 2023, a Director at Affini-T Therapeutics, Inc. since 2022, a Director at Florida Cancer Specialists Foundation, Inc. since 2022, and a Director at Swim Across America, Inc. Former roles include Director at The Children's Health Fund, Independent Director at iTeos Therapeutics, Inc. from 2024 to 2025, Independent Director at Kinnate Biopharma, Inc. from 2023 to 2024, Senior Vice President-US Commercial at Bristol Myers Squibb Co. from 2010 to 2012, Senior Vice President & General Manager at Teva Women's Health, Inc., President-US Oncology at Merck & Co., Inc. from 2014 to 2022, and Senior Vice President-Global Women Health at Teva Pharmaceutical Industries Ltd. from 2012 to 2014.
Education includes undergraduate studies at Northeastern University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 24.06.2026 | 2.337 ( 0,01 % ) | 719 399 $ | 31.07.2026 |
Aktive Positionen von Jill DeSimone
| Unternehmen | Position | Beginn |
|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Direktor/Vorstandsmitglied | 23.05.2022 |
| ONCTERNAL THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 03.01.2023 |
| INDEGENE LIMITED | Direktor/Vorstandsmitglied | 22.01.2026 |
Florida Cancer Specialists Foundation, Inc.
 Florida Cancer Specialists Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Florida Cancer Specialists Foundation, Inc. is a nonprofit organization that supports adult cancer patients and their families by providing non-medical financial assistance. The non-profit company is located in the US. The foundation helps cover essential living expenses such as rent, mortgage, utilities, car payments, and insurance during active cancer treatment. Eligibility criteria include residency, active treatment or recent completion, income at or below 250% of the federal poverty guidelines, and limited liquid assets. The foundation will launch a program called "Nourish Hope" in March 2026, providing $100 grocery gift cards to address food insecurity among financially assisted cancer patients. It also engages in fundraising and awareness initiatives, including community events, corporate partnerships, and art projects. Donations are encouraged through various channels, and the foundation offers resources for organizing community fundraisers. | Direktor/Vorstandsmitglied | 01.04.2022 |
Affini-T Therapeutics, Inc.
 Affini-T Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops T-cell therapies for cancer patients cancer | Direktor/Vorstandsmitglied | 12.07.2022 |
Swim Across America, Inc.
 Swim Across America, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that raises money and awareness for cancer through swimming-related events | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Jill DeSimone
| Unternehmen | Position | Ende |
|---|---|---|
| ITEOS THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 28.08.2025 |
| KINNATE BIOPHARMA INC. | Direktor/Vorstandsmitglied | 03.04.2024 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01.05.2022 |
| ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Jill DeSimone
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
92
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Teva Women's Health, Inc.
 Teva Women's Health, Inc. Pharmaceuticals: MajorHealth Technology Provides women's healthcare products | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Children's Health Fund
 The Children's Health Fund Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Indegene Ltd.
 Indegene Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells drugs & medical devices | Health Technology |
Praxis Precision Medicines, Inc.
 Praxis Precision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops therapies for central nervous system disorders | Health Technology |
Oncternal Therapeutics, Inc.
 Oncternal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that manufactures pharmaceutical products | Health Technology |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage precision oncology company | Health Technology |
iTeos Therapeutics, Inc.
 iTeos Therapeutics, Inc. BiotechnologyHealth Technology Develops immunomodulators for cancer treatments | Health Technology |
Affini-T Therapeutics, Inc.
Affini-T Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops T-cell therapies for cancer patients cancer | Health Technology |
Florida Cancer Specialists Foundation, Inc.
Florida Cancer Specialists Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Florida Cancer Specialists Foundation, Inc. is a nonprofit organization that supports adult cancer patients and their families by providing non-medical financial assistance. The non-profit company is located in the US. The foundation helps cover essential living expenses such as rent, mortgage, utilities, car payments, and insurance during active cancer treatment. Eligibility criteria include residency, active treatment or recent completion, income at or below 250% of the federal poverty guidelines, and limited liquid assets. The foundation will launch a program called "Nourish Hope" in March 2026, providing $100 grocery gift cards to address food insecurity among financially assisted cancer patients. It also engages in fundraising and awareness initiatives, including community events, corporate partnerships, and art projects. Donations are encouraged through various channels, and the foundation offers resources for organizing community fundraisers. | Commercial Services |
Swim Across America, Inc.
Swim Across America, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that raises money and awareness for cancer through swimming-related events | Commercial Services |
